SPECTRAL AI, INC. Business Development
SPECTRAL AI, INC. (MDAI) reported Business Development of $9.70 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessDevelopment · last filed 2026-08-11
- SPECTRAL AI, INC. business development for the quarter ending 2026-03-31 was $9.70M.
| Period end | Business Development | Business Development 1 month | Business Development 3 month |
|---|---|---|---|
| 2026-03-31 | $9.70M 10-Q · filed 2026-08-11 | $9.70M 10-Q · filed 2026-05-13 | |
| 2026-03-18 | $9.70M 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |